EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Pancreatic secretion in man with subclinical vitamin D deficiency






Diabetologia 29(1): 34-38

Pancreatic secretion in man with subclinical vitamin D deficiency

The effects of subclinical vitamin D deficiency and vitamin D supplementation on oral glucose tolerance and secretion of pancreatic hormones were studied in 10 diphenylhydantoin-treated epileptic patients and 15 geriatric patients. Their mean serum concentrations of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 decreased markedly, but returned to normal within 2 weeks of oral supplementation with 25-hydroxyvitamin D3. The serum concentration of ionized calcium was within the normal range before treatment, and remained unchanged. Serum parathyroid hormone was increased during vitamin D deficiency, but decreased significantly (p less than 0.05) afterwards. In vitamin D-deficient epileptic and geriatric patients, the 2- and 3-h insulin levels after glucose ingestion were increased when compared with control values, and glucagon secretion was not suppressed by glucose. Oral glucose tolerance of both groups of patients did not change after 25-hydroxyvitamin D3 supplementation. Insulin secretion remained unchanged in geriatric patients, but was reduced to normal values in epileptic patients. Glucagon suppressibility by glucose was partly restored after vitamin D supplementation in epileptic patients but not in geriatric patients. In contrast to that observed in severely vitamin D-deficient rats or rabbits, correction of subclinical vitamin D deficiency failed to enhance insulin secretion or to improve glucose tolerance in man.

(PDF same-day service: $19.90)

Accession: 006059483

PMID: 3754230

DOI: 10.1007/bf02427278



Related references

Subclinical fat soluble vitamin deficiency in treated patients with pancreatic insufficiency. American Journal of Clinical Nutrition 31(4): 707, 1978

Subclinical vitamin deficiency. 5. The assay of subclinical thiamin deficiency. Ann. Int. Med, 21: 440-446, 1944

Vitamin D deficiency inhibits pancreatic secretion of insulin. Science, USA 4458(209): 823-825, 1980

Vitamin K1 versus vitamin K3 for prevention of subclinical vitamin deficiency: a randomized controlled trial. Indian Pediatrics 44(11): 817-822, 2007

Dietary oxidised frying oil causes oxidative damage of pancreatic islets and impairment of insulin secretion, effects associated with vitamin E deficiency. British Journal of Nutrition 105(9): 1311-1319, 2011

Subclinical vitamin D deficiency in neonates: definition and response to vitamin D supplements. American Journal of Clinical Nutrition 65(3): 771-778, 1997

Effect of severity and duration of subclinical deficiency of vitamin A on the storage of a large dose of the vitamin. International Journal for Vitamin and Nutrition Research. 41: 4, 475-479, 1971

The national vitamin A supplementation program and subclinical vitamin A deficiency among preschool children in the Philippines. Food and Nutrition Bulletin 25(4): 319-329, 2004

Markers of subclinical atherosclerosis in premenopausal women with vitamin D deficiency and effect of vitamin D replacement. Atherosclerosis 237(2): 784-789, 2015

DNA methylation and subclinical vitamin deficiency of folate, pyridoxal-phosphate and vitamin B12 in chronic alcoholics. Clinical Nutrition (Edinburgh) 16(1): 29-35, 1997